CGAS and acute lymphoblastic leukemia: To evaluate the necessity for cGAS in the response of 289 B-ALL cells to CCIs, we used CRISPR-Cas 9 to generate three cGAS knock down (KD) clones targeting exon 2 (KD.38, KD.